Differential effect of a bone morphogenetic protein-7 (OP-1) on primary and revision loaded, stable implants with allograft

Journal of Biomedical Materials Research - Part A

Volumn 71, Issue 4, 2004, Pages 569-576

  Søballe, Kjeld ^a   Jensen, Thomas B ^a   Mouzin, Olivier ^b,c   Kidder, Louis ^b   Bechtold, Joan E ^b  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b MINNEAPOLIS MEDICAL RESEARCH FOUNDATION   (United States)

^c CHU PURPAN   (France)

Author keywords

Allograft; Bone morphogenetic protein; Experimental model; OP 1; Revision joint replacement; Titanium plasma spray implant

Indexed keywords

GRAFTS; IMPLANTS (SURGICAL); JOINTS (ANATOMY); PROTEINS; TITANIUM;

BONE ALLOGRAFT; BONE FORMATION; IMPLANT FIXATION; MINERALIZATION;

BONE;

OSTEOGENIC PROTEIN 1; RECOMBINANT OSTEOGENIC PROTEIN 1; TITANIUM;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTHROPLASTY; ARTICLE; BONE ALLOGRAFT; BONE REMODELING; CONTROLLED STUDY; DISEASE MODEL; DOG; DRUG EFFECT; FEMALE; FEMUR CONDYLE; FRACTURE FIXATION; FRACTURE HEALING; FRACTURE NONUNION; IMPLANT; IMPLANT FIXATION; INTERMETHOD COMPARISON; MINERALIZATION; NONHUMAN; OSSIFICATION; PLASTIC SURGERY; REVISION JOINT REPLACEMENT IMPLANT; TENSILE STRENGTH; TITANIUM IMPLANT; TITANIUM PLASMA SPRAY IMPLANT;

ANIMALS; BIOMECHANICS; BONE AND BONES; BONE DEVELOPMENT; BONE MORPHOGENETIC PROTEINS; BONE TRANSPLANTATION; DOGS; DOSE-RESPONSE RELATIONSHIP, DRUG; PROSTHESES AND IMPLANTS; PROSTHESIS FAILURE; REOPERATION; SURFACE PROPERTIES; TITANIUM; TRANSFORMING GROWTH FACTOR BETA;

EID: 9744221872     PISSN: 00219304     EISSN: None     Source Type: Journal    
DOI: 10.1002/jbm.a.30115     Document Type: Article

References (35)

1. Havelin, Engesaeter LB, Espehaug B, Furnes O, Lie SA, Vollset SE. The Norwegian Arthroplasty Register: 11 years and 73,000 arthroplasties. Acta Orthop Scand 2000;71:337-353.
2. NIH Consensus Conference. Total hip replacement. JAMA 1995;273:1950-1956.
3. Lind M, Krarup N, Mikkelsen S, Horlyck E. Exchange impaction allografting for femoral revision hip arthroplasty: results in 87 cases after 3.6 years' follow-up. J Arthroplasty 2002;17:158-164.
4. Linder L. Cancellous impaction grafting in the human femur: histological and radiographic observations in 6 autopsy femurs and 8 biopsies. Acta Orthop Scand 2000;71:543-552.
5. Willert HG, Ludwig J, Semlitsch M. Reaction of bone to methacrylate after hip arthroplasty. J Bone Joint Surg 1974;56A: 1368-1382.
6. Goldring, Schiller AL, Roelke M, Rourke C, O'Neill DA, Harris WH. The synovial-like membrane at the bone-cement interface in loose total hip replacements and its proposed role in bone lysis. J Bone Joint Surg 1983;65A:575-584.
7. Vestermark MT, Bechtold JE, Swider P, Soballe K. Mechanical interface conditions affect morphology and cellular activity of sclerotic bone rims forming around experimental loaded implants. J Orthop Res 2004;22(3):647-652.
8. Lennox, Schofield BH, McDonald DFRJLH. A histologic comparison of aseptic loosening of cemented, press-fit, and biologic ingrowth prostheses. Clin Orthop 1987;225:171-191.
9. Kozinn, Johanson NA, Bullough PG. The biologic interface between bone and cementless femoral endoprostheses. J Arthroplasty 1986;1:249-259.
10. Jensen TB, Overgaard S, Lind M, Rahbek O, Bunger C, Soballe K. Osteogenic protein 1 device increases bone formation and bone graft resorption around cementless implants. Acta Orthop. Scand 2002a;73:31-39.
11. Jensen TB, Bechtold J, Chen X, Elmengaard B, Soballe K. Platelet concentrate improves fixation achived with morselized bone allograft around non-cemented implants Trans. 49th Annual Meeting Orthopaedic Research Society, 2003.
12. Lind M, Overgaard S, Song Y, Goodman SB, Bunger C, Soballe K. Osteogenic protein 1 device stimulates bone healing to hydroxyapaptite-coated and titanium implants. J Arthroplasty 2000;15:339-346.
13. Tagil M, Jeppsson C, Aspenberg P. Bone graft incorporation. Effects of osteogenic protein-1 and impaction. Clin Orthop and Related Research 2000;71:240-245.
14. Soballe K, Brockstedt Rasmussen H, Hansen ES, Bunger C. Hydroxyapatite coating modifies implant membrane formation. Controlled micromotion studied in dogs. Acta Orthop Scand 1992a;63:128-140.
15. Soballe K, Hansen ES, B.Rasmussen H, Jorgensen PH, Bunger C. Tissue ingrowth into titanium and hydroxyapatite-coated implants during stable and unstable mechanical conditions. J Orthop. Res 1992b;10:285-299.
16. Bechtold JE, Søballe K, Kubic V. A controlled experimental model of revision implants. Part I. Development. Acta Orthop. Scand 2001a;72:642-649.
17. Bechtold JE, Mouzin O, Kidder L, Søballe K. A controlled experimental model of revision implants. Part II. Implementation. Acta Orthop. Scand 2001b;72:650-658.
18. Toft 2004.
19. Søballe K, Mouzin ORG, Kidder LA, Overgaard S, Bechtold JE. The effects of hydroxyapatite coating and bone allograft on fixation of loaded experimental primary and revision implants. Acta Orthop Scand 2003;74:249-247.
20. Goodman SB, Fornasier VL. Particulate debris from medical implants: mechanisms of formation and biological consequences. (Edited by St. John KR). 1992. pp 27-37. ASTM-STP 1144.
21. Eldridge JD, Smith EJ, Hubble MJ, Whitehouse SL, Learmonth ID. Massive early subsidence following femoral impaction grafting. J Arthroplasty 1997;12:535-540.
22. Elting JJ, Mikhail WE, Zicat BA, Hubbell JC, Lane LE, House B. Preliminary report of impaction grafting for exchange femoral arthroplasty. Clin Orthop 1995;319:159-167.
23. Gie GA, Linder L, Ling RS, Simon JP, Slooff TJ, Timperley AJ. Impacted cancellous allografts and cement for revision total hip arthroplasty. J Bone Joint Surg Br 1993;75:14-21.
24. van der, Donk S, Buma P, Slooff TJ, Gardeniers JW, Schreurs BW. Incorporation of morselized bone grafts: a study of 24 acetabular biopsy specimens, Clin Orthop 2002;131-141.
25. Dohmae Y, Bechtold JE, Sherman RE, Puno RM, Gustilo RB. Reduction in cement-bone interface shear strength between primary and revision arthroplasty Clin Orthop 1988;236:214-220.
26. Dreghorn CR, Hamblen DL. Revision arthroplasty: a high price to pay. Br Med J 1989;11-3-;298:648-649.
27. Furnes A, Lie SA, Havelin LI, Engesaeter LB, Vollset SE. The economic impact of failures in total hip replacement surgery: 28,997 cases from the Norwegian Arthroplasty Register, 1987-1993. Acta Orthop Scand 1996;67:115-121.
28. Katz RP, Callaghan JJ, Sullivan PM, Johnston RC. Results of cemented femoral revision total hip arthroplasty using improved cementing techniques. Clin Orthop 1995;319:178-183.
29. Lavernia CJ, Drakeford MK, Tsao AK, Gittelsohn A, Krackow KA, Hungerford DS. Revision and primary hip and knee arthroplasty: a cost analysis. Clin Orthop 1995;311:136-141.
30. Robinson AH, Palmer CR, Villar RN. Is revision as good as primary hip replacement? A comparison of quality of life. J Bone Joint Surg Br 1999;81:42-45.
31. Cook SD. Preclinical and clinical evaluation of osteogenic protein-1 (BMP-7) in bony sites. Orthopedics 1999;22:659-660.
32. Jensen T, Bechtold JE, Cheng X, Kidder L, Soballe K. Autologous Growth Factor (AGF®) in combination with morselized bone allograft improves implant fixation. Trans. 48th Annual Meeting. Orthopaedic Research Society, 2002b.
33. Aspenberg P. Impaction grafting, 14. Acta Orthop. Scand 2001;72:198-199.
34. Cook SD, Baffes GC, Wolfe MW, Sampath TK, Rueger DC, Whitecloud, TS. The effect of recombinant human osteogenic protein-1 on healing of large segmental bone defects. J. Bone Joint Surg Am. 1994;76:827-838.
35. Cook SD, Salkeld SL, Patron LP, Barrack RL. The effect of demineralized bone matrix gel on bone ingrowth and fixation of porous implants. J. Arthroplasty 2002;17:402-408.